Please login to the form below

Not currently logged in
Email:
Password:

bitopertin

This page shows the latest bitopertin news and features for those working in and with pharma, biotech and healthcare.

Abilify Maintena launches in Europe

Abilify Maintena launches in Europe

Prospects for drugs that tackle the latter remain up in the air, however; Roche's bitopertin was leading the field but generated poor results in two phase III trials reported earlier

Latest news

  • Setback for Roche as schizophrenia candidate fails studies Setback for Roche as schizophrenia candidate fails studies

    Like bitopertin both of these were being tested as add-on drugs to tackle negative symptoms, but had different mechanisms of action. ... Analysts have suggested in the past that bitopertin could achieve sales of $3bn or more if it proves effective in

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

brian smith science of the deal
The science of the deal
Business development is more like child-raising than you might think...
The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...

Infographics